35 teams from across the country will compete as students test rockets and science experiments over Lake Michigan ...

In today's competitive and time-sensitive environment, the ability to efficiently translate a promising molecule into a ...

From filming star-like plasma in trillionths of a second to testing a record-breaking lithium thruster and advancing ...

Q1 2026 earnings call recap: rebrand, revenue/EBITDA trends, guidance reaffirmed, margin/cash flow drivers, and buybacks—read more.

NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a potential functional cure in Type 1 ...

It requires renegotiating the social contract that underlies education—who holds power, who earns trust, who gets to make ...

Tanzania, like many countries in Africa, has fought malaria for generations. Our existing tools, from insecticide treated ...

First quarter results showed its order book swelling by US$18.3 billion, a growth of more than 70 per cent year on year. Read ...

Strong start to the year with worldwide revenue of $377.3 million in the first quarter 2026GAAP fully diluted earnings per share of $1.80, compared to $1.02 in the first quarter of 2025Adjusted fully ...

Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal first quarter ended March 29, 2026.

Good day, ladies and gentlemen, and welcome to the Victrex Interim Results. [Operator Instructions] I would like to remind all participants that this call is being recorded. I will now hand over to ...